PALO ALTO, Calif., Aug. 20, 2019 /PRNewswire/
-- Cloudera, Inc., (NYSE: CLDR), the enterprise data
cloud company, today announced that many of the leading global
healthcare and life sciences companies, including 9 of the top 10
global pharmaceutical companies, have chosen Cloudera to guide them
on their journeys to use and benefit from healthcare predictive
analytics.
According to BIS Research, there was a $14.25 billion market for big data in healthcare
in 2017, and by 2025, BIS Research expects that market to grow to
over $68.75 billion. Facilitating
proper care of patient data can be lifesaving, as healthcare data
analytics is emerging as an essential tool for patient diagnoses,
detecting epidemics, enabling genomic analysis, and delivering on
the promise of molecular medicine. The ability to uncover insights
from extremely large data sets is critical as healthcare
organizations work to solve a wide array of global healthcare
concerns.
"Healthcare providers, researchers, medical device designers,
and pharmaceutical developers are consistently improving the
patient outcomes and experience through a deeper understanding of
the data available today across the healthcare ecosystem," said
Abbas Mooraj, Managing Director of Healthcare and Life Sciences at
Cloudera. "It is our goal to provide better, faster, deeper
insights using data, analytics and AI."
Cloudera empowers the healthcare and life sciences industry to
achieve excellent patient experience and drive invaluable medical
research by helping to quickly process, manage, govern and securely
analyze complex, real-time streaming data. The result translates to
an effective use of data and predictive analytics that spurs
innovative use cases in remote patient monitoring, healthcare IoT,
genomics, clinical predictions to precision and value-based
healthcare, and more.
GlaxoSmithKline
GlaxoSmithKline (GSK) is a global pharmaceutical company
with commercial operations in more than 150 countries and Research
& Development (R&D) centers in the United Kingdom, the
United States, Belgium, and
China. The GSK R&D Information
Platform uses Cloudera, partner technologies, and homegrown tools
to deliver a holistic view of all data within R&D and give
researchers an immense analytic advantage. For example, it
previously could take several months to assemble and analyze data
from across multiple clinical trials. Now, with the clinical trial
data standardized and analytics-ready, the same analysis can be
done in minutes. Months to minutes drives significant value. As GSK
achieves greater efficiency and new insights across its many
R&D processes, executives expect to ultimately move the needle
in terms of time-to-market, bringing new drugs and vaccines to
market more quickly and less expensively to help patients.
"We're able to harness the insights across various clinical
trials that give us a different perspective on the overall equation
of a single therapeutic area or multiple therapeutic areas. What
this does for us is help make the lives of our patients better,
leading to different kind of avenues of discovering medicine," said
Ranjith Raghunath, Director, Big
Data Solutions, GSK.
Quanam
Quanam is a multi-Latin federation of firms specializing in
consulting and management, professional services, communication and
change management. Quanam, partnering with GenLives, had the goal
of allowing clinicians to make more accurate diagnoses in shorter
timeframes. Quanam needed a way to isolate the information
responsible for causing pathogenic conditions. Geneticists also had
to sift through millions of existing academic papers manually,
trying to identify these conditions. For this goal to become a
reality, Quanam needed a big data platform that could withstand
demanding storage and computing requirements to process multiple
complex algorithms. With Cloudera's platform, the company could
analyze and store large volumes of data, and offered a foundation
on which machine learning algorithms could be run. Clinical
geneticists can now make more informed decisions on the dangers of
genome variants. DNA sequencing now takes a matter of hours, rather
than an entire day. This results in a faster diagnosis, from an
average of 5 years, down to 8-10 weeks.
"We're convinced Cloudera is a great option, especially in
providing a proven infrastructure for both data at rest and data in
motion," said Fernando Lopez,
Business Analytics - Big Data, Quanam.
Quest Diagnostics
Quest Diagnostics is a leading provider of diagnostic
insights focused on improving patient outcomes. Quest annually
serves one-third of the adult population in the United States and works with half the
physicians and hospitals, resulting in the largest repository of
clinical results in the United
States. Quest uses Cloudera Enterprise to easily combine
structured data from its data warehouses with unstructured data
from a variety of sources. With all the data together in an
enterprise data hub, the platform can support a variety of
initiatives, including advancing data science, data warehouse, and
operational database workloads. Additionally, Cloudera addressed
data governance concerns in the healthcare industry through
Cloudera Navigator. With Cloudera Navigator, Quest can monitor data
access, enforce policies based on the Health Insurance Portability
and Accountability Act (HIPAA) requirements, and demonstrate
compliance.
"The Cloudera Enterprise platform is the cornerstone of our
next-generation analytics platform, and the outstanding partnership
we have developed with Cloudera has allowed us to quickly
aggregate, cleanse, enrich, and visualize our data in ways we
struggled with in the past," explained Bill
Leister, VP of Analytics, Informatics and Business
Intelligence. "With our data lake, we can present insights
that drive operational efficiency, enrich our clinical reports, and
support the growing need to manage population health and lab
utilization."
Additional Resources
For more information about Cloudera's Healthcare Solutions,
please visit:
https://www.cloudera.com/solutions/healthcare.html
https://hortonworks.com/solutions/healthcare/
Read more about Cloudera's enterprise customers here:
https://www.cloudera.com/about/customers.html
About Cloudera
At Cloudera, we believe that data can
make what is impossible today, possible tomorrow. We empower people
to transform complex data into clear and actionable insights.
Cloudera delivers an enterprise data cloud for any data, anywhere,
from the Edge to AI. Powered by the relentless innovation of the
open source community, Cloudera advances digital transformation for
the world's largest enterprises. Learn more at Cloudera.com.
Cloudera and associated marks are trademarks or registered
trademarks of Cloudera, Inc. All other company and product names
may be trademarks of their respective owners.
Media Contact:
Rhodes Klement
press@cloudera.com
+1 (650) 644-3900
View original content to download
multimedia:http://www.prnewswire.com/news-releases/leading-pharmaceutical-and-healthcare-organizations-rely-on-cloudera-to-power-predictive-data-insights-300904080.html
SOURCE Cloudera, Inc.